Press Releases | Medtronic

Month Year

Email alerts

Feb 3, 2013

Minnesota Timberwolves Star Ricky Rubio Teams Up with Medtronic Foundation to Save Young Lives from Sudden Cardiac Arrest

Rubio Helps Web Visitors Save a "Virtual" Life at HeartRescueNow.com

MINNEAPOLIS, February 5, 2013 -Minnesota Timberwolves basketball star Ricky Rubio joins the Medtronic Foundation this February in saving young lives worldwide from sudden cardiac arrest (SCA)....
Jan 30, 2013

Medtronic Introduces the First and Only Neurostimulation Systems with CE Mark Approval for Full-Body MRI Scans

TOLOCHENAZ AND MINNEAPOLIS - January 30, 2013 - Medtronic, Inc. (NYSE: MDT) today introduced in Europe the first and only implantable neurostimulation systems indicated for use in the treatment of...
Jan 30, 2013

Medtronic Completes Strategic Investment in LifeTech Scientific Corporation

Strategic Alliance to Leverage Best of Both Companies to Reach Cardiovascular Patients in China and Other Emerging Markets

MINNEAPOLIS and Shenzhen - January 30, 2013 - Medtronic, Inc. (NYSE:MDT) and LifeTech Scientific Corporation (8122:HK) today announced the closing of a transaction creating a strategic alliance...
Jan 28, 2013

Medtronic Initiates Landmark Study of Neurostimulation Therapy for Failed Back Surgery Syndrome

First Patients Treated in Global Clinical Trial Evaluating Impact of Therapy on Predominant Low Back Pain

MINNEAPOLIS - January 28, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low...
Jan 24, 2013

Medtronic Launches Lower-Extremity Indication for Complete 'SE' Vascular Stent Internationally

Self-Expanding Peripheral Device Gets CE Mark for Superficial Femoral and Proximal Popliteal Arteries

MINNEAPOLIS -- Jan. 24, 2013 -- Expanding its role in the treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) today announced the CE (Conformité Européene) mark and international...
Jan 23, 2013

Medtronic Drug-Eluting Balloon Study Completes Enrollment

Milestone in IN.PACT SFA II Brings FDA Submission for Promising Interventional Treatment of Peripheral Artery Disease One Step Closer in U.S.

MINNEAPOLIS -- Jan. 23, 2013 -- Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting...
Jan 16, 2013

New Clinical Trial Will Use Continuous Cardiac Monitoring to Evaluate Atrial Fibrillation in High-Risk Patients

Medtronic Announces First Patient Implant in REVEAL AF Clinical Trial

MINNEAPOLIS - January 16, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the first patient implant for the REVEAL AF (Incidence of AF in High Risk Patients) Clinical Trial, which through...
Jan 15, 2013

Medtronic Announces Launch of FlexCath Advance(TM) Steerable Sheath, Enhancing the Arctic Front Advance(TM) Cryoballoon System

Second-Generation Sheath May Facilitate Easier Access to the Inferior Veins When Treating Paroxysmal Atrial Fibrillation

MINNEAPOLIS - Jan. 15, 2013 - Medtronic, Inc. (NYSE: MDT) today announced Food and Drug Administration (FDA) clearance and U.S. launch of the FlexCath Advance(TM) Steerable Sheath, a new...
Jan 10, 2013

New Clinical Trial First To Evaluate Effectiveness of CRT-P in Symptomatic Heart Failure Patients with Mild-to-Moderate Structural Heart Disease

Medtronic-Sponsored Study Aims to Support Worldwide Indication Expansion for CRT-P in a Significantly Underserved Heart Failure Patient Population

MINNEAPOLIS - Jan. 10, 2013 - Medtronic, Inc. (NYSE: MDT) today announced the first patient enrollment in MIRACLE EF, a global clinical trial that will evaluate the effectiveness of cardiac...
Jan 7, 2013

Medtronic Updates Fiscal 2013 EPS Guidance

MINNEAPOLIS - January 7, 2013 - In a presentation to investors, Medtronic, Inc. (NYSE:MDT) today updated diluted earnings per share (EPS) guidance for fiscal year 2013. The Company tightened its...

Show per page